The Mercury (Pottstown, PA)

Britain approves controvers­ial gene-editing experiment­s

- By Maria Cheng

LONDON >> In a landmark decision that some ethicists warned is a step down the path toward “designer babies,” Britain gave scientists approval Monday to conduct experiment­s in which they will try to edit the genes in human embryos.

The scientists won’t be creating babies — the modified embryos will be destroyed after seven days. Instead, they said, the goal is to better understand human developmen­t and thereby improve fertility treatments and prevent miscarriag­es.

The decision by Britain’s Human-Fertilisat­ion and Embryology Authority marks the first time a county’s national regulator has approved the technique. Permission isn’t explicitly required in many other countries, including the U.S. and China. The U.S. does not allow the use of federal funds for embryo modificati­on, but there is no outright ban on gene editing.

Gene editing involves deleting, repairing or replacing DNA inside living cells in a sort of biological cut-and-paste technique that scientists say could one day lead to treatments for conditions like HIV or inherited disorders such as muscular dystrophy and sickle cell disease.

A team led by Kathy Niakan, an embryo and stem cell specialist at London’s new Francis Crick Institute, received the OK to use gene editing to analyze the first week of an embryo’s growth.

This research will “enhance our understand­ing of IVF (in vitroferti­lization) success rates by looking at the very earliest stage of humandevel­opment,” said Paul Nurse, directorof the institute.

None of the embryos will be transferre­d into women. They will be allowed to develop from a single cell to around 250 cells, afterwhich they will be destroyed.

Peter Braude, a retired professor of obstetrics and gynecology at King’s College London, said the mechanisms being investigat­ed by Niakan and her colleagues “are crucial in ensuring healthy, normal developmen­t and implantati­on” and could help doctors refine fertility treatments. Braude is not connected to Niakan’s research.

There are a few methods of gene editing, but the technique Niakan’s team plans to use is known as CRISPRC as 9, a relatively fast, cheap and simple approach that many researcher­s are keen to try.

Some critics warn that tweaking the genetic code this way could be a slippery slope that eventually leads to designer babies, where parents not only aim to avoid inherited diseases but also seek taller, stronger, smarter or better-looking children.

Many religious groups, including the Catholic Church, object to people “playing God” and manipulati­ng embryos. Some scientists have voiced concern that tampering with genes might have unintended consequenc­es not apparent until after the babies are born — or generation­s later. And some fear such tinkering will only widen the gap between rich and poor by enabling the wealthy to create superbabie­s.

“This is the first step on a path that scientists have carefully mapped out towards the legalizati­on” of geneticall­y modified babies, David King of the advocacy group Human Genetics Alert said last month when British regulators took up the issue.

Around the world, laws and guidelines vary widely about what kind of research is allowed on embryos, since such experiment­s could change the genes of future generation­s. Countries such as Japan, China, India and Ireland have unenforcea­ble guidelines that restrict editing of the human genome. Germany and other countries in Europe limit research on human embryos by law.

Newspapers in English

Newspapers from United States